药康生物(688046.SH)：上半年净利润7090.55万元，同比下降7.12%

Core Insights - The company reported a revenue of 375 million yuan for the first half of 2025, representing a year-on-year growth of 10.11% [1] - The net profit attributable to shareholders decreased by 7.12% to 70.91 million yuan [1] - The net profit excluding non-recurring gains and losses increased by 14.75% to 62.93 million yuan [1] - Basic earnings per share were reported at 0.17 yuan [1] - The company plans to distribute a cash dividend of 0.30 yuan per 10 shares (including tax) to all shareholders [1]